標(biāo)題: Titlebook: Blood and Marrow Transplant Handbook; Comprehensive Guide Richard T. Maziarz,Susan Schubach Slater Book 2021Latest edition Springer Nature [打印本頁] 作者: Debilitate 時(shí)間: 2025-3-21 16:27
書目名稱Blood and Marrow Transplant Handbook影響因子(影響力)
書目名稱Blood and Marrow Transplant Handbook影響因子(影響力)學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook網(wǎng)絡(luò)公開度
書目名稱Blood and Marrow Transplant Handbook網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook被引頻次
書目名稱Blood and Marrow Transplant Handbook被引頻次學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook年度引用
書目名稱Blood and Marrow Transplant Handbook年度引用學(xué)科排名
書目名稱Blood and Marrow Transplant Handbook讀者反饋
書目名稱Blood and Marrow Transplant Handbook讀者反饋學(xué)科排名
作者: SEEK 時(shí)間: 2025-3-21 23:54
Design Principles and Techniquess with relapsed or refractory disease after initial cisplatin-based chemotherapy. The use of tandem transplant with high-dose carboplatin and etoposide conditioning in this setting has been a standard in the United States based on the large experience from Indiana University. Ongoing randomized trials seek to confirm this approach.作者: 善于 時(shí)間: 2025-3-22 03:08 作者: 血友病 時(shí)間: 2025-3-22 08:17 作者: Collected 時(shí)間: 2025-3-22 11:38
Ulrike Brandi,Christoph Geissmar-Brandiations where no other potentially curative treatment options exist. Advances in immunogenetics and immunobiology, conditioning regimens, disease characterization and risk stratification, immune suppression, antimicrobials, and other types of supportive care have all contributed to improvements in di作者: 形容詞 時(shí)間: 2025-3-22 14:33 作者: 施舍 時(shí)間: 2025-3-22 20:51 作者: sundowning 時(shí)間: 2025-3-22 21:29 作者: jaundiced 時(shí)間: 2025-3-23 02:18 作者: Metamorphosis 時(shí)間: 2025-3-23 08:02
Historical Facade: Hamburg Town Hallt immune system and treat their underlying malignancy. These therapeutic combinations are collectively known as the conditioning or preparative regimens. Chosen specifically for their activity against the underlying malignancy, these agents also decrease the risk of graft rejection and create physio作者: ALIAS 時(shí)間: 2025-3-23 11:52 作者: Palpitation 時(shí)間: 2025-3-23 17:33
Boulevard: “Bürger” in Bremerhavend between the worlds of pediatric and adult oncology (Zebrack, J Clin Oncol 28:4862–7, 2010). This group of individuals is now identified in clinical trials and in clinical care as the adolescent and young adult (AYA) population. Historically, hematopoietic cell transplant (HCT) has been applied sel作者: 是限制 時(shí)間: 2025-3-23 18:23 作者: euphoria 時(shí)間: 2025-3-24 01:40
Design Principles and Techniques As a result of research into the human leukocyte antigen (HLA) system, immunological interactions between donor and host, and use of different donor types, nearly all eligible patients now have a suitable donor. Unfortunately, graft-versus-host disease (GvHD), incited by immunocompetent donor cells作者: libertine 時(shí)間: 2025-3-24 03:47
Riverside Walk: Jungfernstieg, Hamburg choose the best transfusion product before, during, and after HCT. Furthermore, clinical status and successful communications between the transplant team and transfusion services (TS) are essential for the optimal management of HCT patients in order to reduce the risk of alloimmunization, infection作者: 子女 時(shí)間: 2025-3-24 09:03
Fountains and Monuments: Schonbrunn, Viennagnancies, as well as for increased bleeding. Use of anticoagulant and antiplatelet agents in this population can be challenging given unique risk factors for both thrombosis and bleeding including frequent, significant disease- or treatment-related thrombocytopenia, systemic inflammation related to 作者: 精致 時(shí)間: 2025-3-24 12:51
Riverside Walk: Jungfernstieg, Hamburgmposition, conditioning intensity, graft versus host disease (GvHD) prophylaxis, and a variety of other host- and transplant-related variables. Delays in engraftment can lead to prolonged hospitalization, transfusion dependency, and increased risk of infection, thus affecting treatment-related morta作者: 苦惱 時(shí)間: 2025-3-24 16:44
Shopping Centre: London White Citynderstanding of the disease biology. Identification of molecular markers for disease monitoring and prognostication, along with targeted therapies in select populations, is translating into improved patient outcomes.作者: 收集 時(shí)間: 2025-3-24 21:56
Fountains and Monuments: Schonbrunn, Viennakemia (ALL) who present with either high risk or relapsed disease, despite the limited graft-versus-leukemia (GvL) effect that has been observed after allogeneic HCT. Intensive chemotherapy regimens have previously decreased the need for transplantation procedures for pediatric and adolescent/young 作者: Synovial-Fluid 時(shí)間: 2025-3-25 00:41 作者: indenture 時(shí)間: 2025-3-25 05:29 作者: Incisor 時(shí)間: 2025-3-25 08:57
Design Principles and Techniquess with relapsed or refractory disease after initial cisplatin-based chemotherapy. The use of tandem transplant with high-dose carboplatin and etoposide conditioning in this setting has been a standard in the United States based on the large experience from Indiana University. Ongoing randomized tria作者: conservative 時(shí)間: 2025-3-25 13:27 作者: 審問,審訊 時(shí)間: 2025-3-25 16:00
978-3-030-53625-1Springer Nature Switzerland AG 2021作者: Inelasticity 時(shí)間: 2025-3-25 21:48
Richard T. Maziarz,Susan Schubach SlaterOffers indications for transplant, essential details for patient/donor evaluation, and recommendations for management of complications.Features step-by-step instructions for common procedures and docu作者: 節(jié)省 時(shí)間: 2025-3-26 01:36 作者: 卡死偷電 時(shí)間: 2025-3-26 05:31 作者: 卵石 時(shí)間: 2025-3-26 10:17 作者: 虛弱的神經(jīng) 時(shí)間: 2025-3-26 15:06 作者: LASH 時(shí)間: 2025-3-26 18:18
Fountains and Monuments: Schonbrunn, Viennaor antiplatelet therapy for patients already on these drugs, and how to manage patients who develop new indications for these drug classes during the HCT process. Indications for anticoagulation typically fall under three main categories: (1) venous thromboembolic disease (VTE), (2) atrial fibrillat作者: 微生物 時(shí)間: 2025-3-26 23:48 作者: Kaleidoscope 時(shí)間: 2025-3-27 01:20
Nutrition,ised patient population is essential. Thus, the rationale for a controlled low bacteria diet, GvHD diet restrictions, and general diet guidelines are provided..Also reviewed are the goals for nutrition during HCT and guidelines for initiation of total parenteral nutrition (TPN) and enteral nutrition作者: CHAR 時(shí)間: 2025-3-27 05:55 作者: Fracture 時(shí)間: 2025-3-27 12:54 作者: 有限 時(shí)間: 2025-3-27 17:33
oach to information for physicians and advanced practice medical providers as well as residents, fellows, and other trainees who care for patients who undergo transplant and immune effector cell therapy..978-3-030-53625-1978-3-030-53626-8作者: 的’ 時(shí)間: 2025-3-27 18:07
res step-by-step instructions for common procedures and docu.This updated and expanded edition developed by the Blood and Marrow Stem Cell Transplant team at Oregon Health & Science University Knight Cancer Institute features the latest medical management guidelines and standards of care for hematop作者: dagger 時(shí)間: 2025-3-28 01:36 作者: deviate 時(shí)間: 2025-3-28 04:55
Ulrike Brandi,Christoph Geissmar-Brandiosures in the setting of altered host immune response. Prevention of infection by way of prophylactic and preemptive strategies has been associated with improvement in transplant outcomes over the past few decades.作者: Accord 時(shí)間: 2025-3-28 07:50 作者: Biofeedback 時(shí)間: 2025-3-28 11:21
Historical Facade: Hamburg Town Hallves outcomes, and allogeneic HCT (alloHCT) can be curative in multiply relapsed disease. HCT is also effective in less common lymphomas like peripheral T-cell lymphoma and primary central nervous system (CNS) lymphoma. Maintenance therapy after transplant improves outcomes in HL, follicular lymphoma, and mantle cell lymphoma.作者: Texture 時(shí)間: 2025-3-28 18:38 作者: 四溢 時(shí)間: 2025-3-28 22:43 作者: lesion 時(shí)間: 2025-3-29 01:54
Engraftment, in engraftment can lead to prolonged hospitalization, transfusion dependency, and increased risk of infection, thus affecting treatment-related mortality. Engraftment syndrome is a unique, usually reversible complication arising after autologous transplantation (ASCT) which needs to be recognized early for effective therapy.作者: Rejuvenate 時(shí)間: 2025-3-29 05:49 作者: lambaste 時(shí)間: 2025-3-29 10:32 作者: Defraud 時(shí)間: 2025-3-29 14:40 作者: 變白 時(shí)間: 2025-3-29 16:19
Fountains and Monuments: Schonbrunn, Viennaadult (AYA) patients. Recent advances in the detection of minimal residual disease (MRD) and expansion of therapeutic options for the management of ALL, particularly in the adults, call into question pre-existing transplant algorithms for ALL management.作者: amphibian 時(shí)間: 2025-3-29 19:45
Boulevard: “Bürger” in Bremerhavenrole of tandem and salvage transplants. Guidance to assess transplant eligibility and practical recommendations for supportive care and maintenance therapy after autologous transplantation is also provided.作者: idiopathic 時(shí)間: 2025-3-30 01:02
Overview of Hematopoietic Cell Transplantation and Cellular Therapy,sease control and overall survival. Currently, there is the emerging field of immune effector cell therapy, based on the ability to manufacture at large scale various immune cell populations which is now rapidly changing the landscape of cancer care.作者: 鋼筆記下懲罰 時(shí)間: 2025-3-30 08:08 作者: HEED 時(shí)間: 2025-3-30 08:16 作者: mitral-valve 時(shí)間: 2025-3-30 13:54 作者: bacteria 時(shí)間: 2025-3-30 17:04
https://doi.org/10.1007/978-3-7643-8263-6ity guidelines, and HCT donor evaluation. A broad understanding of patient health prior to HCT is critical in optimizing not only patient and conditioning regimen selection, but also in developing individualized patient counseling and supportive care plans.作者: Munificent 時(shí)間: 2025-3-30 21:45 作者: Laconic 時(shí)間: 2025-3-31 01:48
Pretransplant Assessment for Hematopoietic Cell Transplantation Recipients and Donors,ity guidelines, and HCT donor evaluation. A broad understanding of patient health prior to HCT is critical in optimizing not only patient and conditioning regimen selection, but also in developing individualized patient counseling and supportive care plans.作者: 誤傳 時(shí)間: 2025-3-31 05:44
Conditioning Regimens,rmed for a nonmalignant disorder, the conditioning regime is chosen for its immune-suppressive properties. This chapter lists common regimens, provides guidance on drug dosing in different populations, and provides agent-specific insight into supportive care practices.作者: Hyperalgesia 時(shí)間: 2025-3-31 12:16 作者: tendinitis 時(shí)間: 2025-3-31 13:58 作者: 受人支配 時(shí)間: 2025-3-31 18:09
Social Work: Evaluation and Social Supports,brings their past medical, emotional, financial, and personal experiences, which influence their ability to tolerate the ardors of transplant. This chapter will focus on the psychosocial issues along the continuum of care that are important for social workers and psychosocial experts to assess and address.作者: 小蟲 時(shí)間: 2025-3-31 21:58 作者: 煩人 時(shí)間: 2025-4-1 05:47
Book 2021Latest editionok: Comprehensive Guide for Patient Care, Third Edition .presents a multidisciplinary approach to information for physicians and advanced practice medical providers as well as residents, fellows, and other trainees who care for patients who undergo transplant and immune effector cell therapy..作者: 保存 時(shí)間: 2025-4-1 07:55 作者: Insatiable 時(shí)間: 2025-4-1 12:17 作者: 嫻熟 時(shí)間: 2025-4-1 17:29
The Business of Cellular Therapy and Hematopoietic Cell Transplantation,etic cell transplant (HCT)/cellular therapy programs. As with clinical care, the business of HCT/cellular therapy is ever evolving. This chapter highlights those areas clinical program directors or administrative leaders should be aware of and investigate further..Information provided in this chapte作者: 不適 時(shí)間: 2025-4-1 21:39
